Supporting the Mental Health Workforce

April 9, 2024 updated by: Louis D. Brown, The University of Texas Health Science Center, Houston

Local Organizational Support and Development Networks for Public Mental Health System Workforce With Lived Experience

Emotional Health Association will engage Los Angeles County Department of Mental Health providers that employ peer workers in a training and technical assistance intervention designed to support, increase, and retain an effective peer workforce. This intervention consists of a Co-Learning Collaborative, several training sessions, and the creation of Implementation Teams. Peer workers will also be encouraged to attend Recovery International, an established network of self-help support groups for mental health. Dr. Louis Brown will lead an evaluation of the efficacy of the intervention. This study will inform the use of peer workers as a component of the mental health workforce.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Evaluation of the the intervention with the peer workforce will be conducted through administration of web-based surveys of peer workers and peer supervisors at baseline and follow-up (10 months post-baseline). These two surveys will be administered to peer workers and peer supervisors at sites enrolled in the study. A letter of informational detailing the risks of participation will accompany the survey. Individuals who do not complete the web-based survey will be invited to complete a telephone interview with the same questions. Sites (where one or more peer supervisors and peer workers are located) will be randomized to either the intervention group or standard practice control group. The intervention group will engage in Co-Learning Collaborative, several training sessions, and the creation of Implementation Teams. Peer workers from the intervention group will also be encouraged to attend Recovery International, an established network of self-help support groups for mental health. Analysis of the surveys collected from both study groups will be conducted to assess the efficacy of the intervention and provide Emotional Health Association with a final report.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
366

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • Culver City, California, United States, 90230
        • SHARE! Self-Help and Recovery Exchance

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All service providing sites within the Los Angeles Department of Mental Health will be invited to participate in the study. Sites not affiliated with the Los Angeles Department of Mental Health will be allowed to enroll in the study if they express interest but will not be actively recruited.
  • Participants must be a peer worker or supervisor of peer workers at a site participating in the study.

Exclusion Criteria:

  • Peers who do not receive pay and volunteer for less that 15 hours per week.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Mental Health Peer Workforce Support
Sites assigned to this group will engage in Co-Learning Collaborative, several trainings, and the creation of Implementation Teams--all part of the intervention and designed to support their peer workforce.
Behavioral: Mental Health Peer Workforce Support

Supervisors and peer workers will participate in trainings covering effective peer services, trauma-informed effective peer supervision, and responsibilities of peer workers in a supervising relationship. A monthly Supervisors of Peer Workers meeting will support site change efforts. Sites will create an implementation team to work within their site to implement the training received.

Peer Workers will enroll in a peer mentoring program, where they serve as peer mentors matched with fellow peer mentors. Recovery International and the Los Angeles Department of Mental Health will encourage peer workers to attend Recovery International meetings. Emotional Health Association will refer Peer Workers and their Supervisors in the intervention group to self-help support groups that reduce stress and increase resiliency.
No Intervention: Control Group
Sites assigned to this group will continue practice as usual and not receive any additional peer worker training or technical assistance.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Peer-supportive organizational climate
Time Frame: 10 months

Peer-supportive organizational climate will be assessed by a set of 6 likert-scale questions that asks about the participant about his/her organization's administrative leadership and the support they provide.

1= Strongly Disagree (with positive statement about organization) 7= Strongly Disagree (with positive statement about organization)
10 months
Mental Health Stigma
Time Frame: 10 months

This outcome will be assessed by asking the peer supervisor a set of 15 likert-scale questions about their feelings towards individuals with mental health issues.

1= Strongly Disagree 5= Strongly Agree
10 months
Peer Worker Recovery
Time Frame: 10 months

This outcome will be assessed by a set of 24 likert scale questions that ask the participants how they feel about themselves and their lives.

1= Strongly Disagree (with positive statement about self) 5= Strongly Agree (with positive statement about self)
10 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Recovery orientation of services
Time Frame: 10 Months

This outcome will be measured with 4 questions that ask the peer workers to rate their level of agreement with statements about their organization's treatment of service users (or clients)

1= Strongly Disagree (with positive statement about services) 7= Strongly Agree (with positive statement about services)
10 Months
Supervisor's peer support attitudes
Time Frame: 10 Months

This outcome will be assessed by asking the peer supervisor a set of three likert-scale questions about the importance of peer support for mental health services.

1=Not important at all 10 =Extremely Important
10 Months
Supervisor's job satisfaction
Time Frame: 10 Months
This outcome will be measured using one likert-scale question that asks how satisfied the supervisors are with their job- from 1 (highly unsatisfied) to 5 (very satisfied).
10 Months
Supervision quality (as rated by peer workers)
Time Frame: 10 Months

This outcome will be assessed with a set of 7 likert scale questions that ask about the peer worker's experience with their supervisor.

1= Strongly Disagree (with positive statement about supervisor) 7= Strongly Agree (with positive statement about supervisor)
10 Months
Peer worker time spent on peer support activities
Time Frame: 10 Months
This outcome will be measured by asking the peer workers to rate how much time they spend on 9 different support activities on a typical week-- from "None" to "40 hours plus".
10 Months
Peer worker discrimination experience
Time Frame: 10 Months

This will be measured with a set of 5 likert scale questions that asks the peer worker about their experience with discrimination due to their mental health.

1= Strongly Disagree (with statement about negative experience) 5= Strongly Agree (with statement about negative experience)
10 Months
Supervisor/peer worker relationship (as rated by supervisor)
Time Frame: 10 Months

This outcome will be measured by a set of 12 likert scale questions from the Supervisory Relationship Measure developed by Pearce et al. 2012.

1= Strongly Disagree (with positive statement about peer worker) 5= Strongly Agree (with positive statement about peer worker)
10 Months
Peer worker contributions (as rated by supervisor)
Time Frame: 10 Months

This outcome will be measured by a set of 12 likert scale questions.

1= Strongly Disagree 7= Strongly Agree
10 Months
Peer worker job satisfaction
Time Frame: 10 Months
This outcome will be measured using one likert-scale question that asks how satisfied the peer workers are with their job- from 1 ("highly unsatisfied") to 5 ("very satisfied").
10 Months
Peer worker sick leave and disability days
Time Frame: 10 Months

This outcome will be measured with the following question from the Stapelfeldt et al 2012 instrument:

"How many sick leave or disability days has _____ had within the last 6 months?"
10 Months
Peer worker work-related burnout
Time Frame: 10 Months

This will assesses with a set of 7 likert scale questions that ask the peer worker for the frequency of certain experiences at their job.

1= Always 5= Never/Almost Never
10 Months
Peer worker mental health problems
Time Frame: 10 Months

This outcome will be assessed by a set of 27 likert-scale questions that asks the participant how frequent they have experienced feelings of distress in the past 30 days.

1= Not all (pertaining to negative statement) 5= Extremely (pertaining to negative statement)
10 Months
Peer worker social support
Time Frame: 10 Months

This outcome will be assessed by having the peer workers answer some questions about the people in their environment who provide them with help or support.

1= Very satisfied (with specific person's support) 6= Very dissatisfied (with specific person's support)
10 Months
Peer worker stress
Time Frame: 10 Months

This outcome will be measured by a set of 6 likert scale questions that ask the peer worker to rate the frequency that they have had stressful experiences in the past 30 days.

1= Never (pertaining to negative statement) 5= Very Often (pertaining to negative statement)
10 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
The University of Texas Health Science Center, Houston

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Emotional Health Association
California Office of Statewide Health Planning and Development

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Louis D Brown, PhD, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 23, 2018

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 7, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 7, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 12, 2018

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 16, 2018

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 17, 2018

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 10, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 9, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • HSC-SPH-18-0357

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Mental Health Peer Workforce Support

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings